Humanized NOD/SCID/IL2rγ null mice exhibit functionally augmented human regulatory T cells associated with enzymatic up‐regulation of H3K27me3 in comparison with humans

Summary Humanized non‐obese diabetic/severe combined immunodeficiency/interleukin‐2 receptor‐γ‐null (NOD/SCID/IL2rγ null ) [humanized (huNSG)] mice engrafted with human hematopoietic cells have been used for investigations of the human immune system. However, the epigenetic features of the human regulatory T (T reg ) cells of huNSG mice have not been studied. The objective of this study was to clarify the characteristics of human T reg cells in huNSG mice, especially in terms of the epigenetic aspects. We compared the populations, inhibitory molecule expression and suppressive capacity of human T reg cells in spleens harvested from the huNSG mice 120 days after the engraftment of human umbilical cord blood CD34 + cells with human peripheral blood mononuclear cells (PBMCs). Histone modifications and enhancer of zeste homolog 2 (Ezh2), an H3K27 methyltransferase, of human T reg cells were quantified in huNSG mice and human PBMCs. The effect of Ezh2 inhibitor on human T reg cells exposed to interleukin (IL)‐6 was also compared between them. Human T reg cells in the spleens of huNSG mice showed an increased proportion among CD4 + T cells, higher expressions of forkhead box protein 3 (FoxP3), cytotoxic T lymphocyte antigen 4 (CTLA‐4) and glucocorticoid‐induced tumor necrosis factor‐related protein (GITR), a higher production of IL‐10 and enhanced suppressive capacity when compared with those in human PBMCs. H3K27me3 and Ezh2 were specifically up‐regulated in human T reg cells of huNSG mice in comparison with those of human PBMCs. The decrease in T reg cells induced by IL‐6 exposure was attenuated in huNSG mice when compared with human PBMCs, while the difference between them was cancelled by addition of Ezh2 inhibitor. In conclusion, huNSG mice exhibit functionally augmented human T reg cells owing to enzymatic up‐regulation of H3K27me3.